The global healthcare landscape is witnessing a critical resurgence of Treponema pallidum infections, driving the Syphilis Immunoassay Diagnostics Industry into a high-growth phase. Once considered a receding public health threat, syphilis has re-emerged due to shifting socioeconomic factors, increased high-risk behaviors, and a significant rise in congenital syphilis cases....